Inhibitor Therapeutics, Inc. (INTI) is a Delaware-incorporated biopharmaceutical company focused on developing and commercializing therapeutic product candidates. The company seeks to advance its pipeline through clinical trials requiring FDA or other regulatory approval, and pursues securing development and commercialization partners. Specific product candidates are not detailed in the provided section of the filing.
Q2 FY2026 — expected 2026-08-21
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-26 | 2025-12-31 | 0001493152-26-012751 | EDGAR | 39K words |
| 2025-03-28 | 2024-12-31 | 0001641172-25-001190 | EDGAR | — |
| 2024-03-29 | 2023-12-31 | 0001493152-24-011973 | EDGAR | — |
| 2023-03-31 | 2022-12-31 | 0001493152-23-010383 | EDGAR | — |
| 2022-03-30 | 2021-12-31 | 0001193125-22-088832 | EDGAR | — |
| 2021-03-26 | 2020-12-31 | 0001193125-21-095516 | EDGAR | — |
| 2020-03-30 | 2019-12-31 | 0001193125-20-090201 | EDGAR | — |
| 2019-03-07 | 2018-12-31 | 0001193125-19-066503 | EDGAR | — |
| 2018-02-16 | 2017-12-31 | 0001193125-18-047834 | EDGAR | — |
| 2017-02-17 | 2016-12-31 | 0001193125-17-048025 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-13 | 2025-09-30 | 0001493152-25-022178 | EDGAR | 11K words |
| 2025-08-13 | 2025-06-30 | 0001641172-25-023465 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0001641172-25-010110 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001493152-24-044473 | EDGAR | — |
| 2024-08-06 | 2024-06-30 | 0001493152-24-030381 | EDGAR | — |
| 2024-05-13 | 2024-03-31 | 0001493152-24-018805 | EDGAR | — |
| 2023-11-13 | 2023-09-30 | 0001493152-23-040351 | EDGAR | — |
| 2023-08-11 | 2023-06-30 | 0001493152-23-027740 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0001493152-23-016967 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001193125-22-284610 | EDGAR | — |
| 2022-08-12 | 2022-06-30 | 0001193125-22-219960 | EDGAR | — |
| 2022-05-13 | 2022-03-31 | 0001193125-22-149504 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-04-01 | 0001493152-26-014637 | EDGAR | 1K words |
| 2026-04-01 | 0001493152-26-014517 | EDGAR | — |
| 2026-02-24 | 0001493152-26-007821 | EDGAR | — |
| 2025-10-27 | 0001493152-25-019381 | EDGAR | — |
| 2023-12-14 | 0001193125-23-294696 | EDGAR | — |
| 2023-10-18 | 0001193125-23-258156 | EDGAR | — |
| 2023-08-29 | 0001193125-23-223590 | EDGAR | — |
| 2023-05-31 | 0001493152-23-019651 | EDGAR | — |
| 2022-12-19 | 0001193125-22-308415 | EDGAR | — |
| 2022-09-15 | 0001193125-22-245701 | EDGAR | — |
310 total filings indexed. 278 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001042418 |
| Ticker | INTI |
| Exchange | OTC |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report